Respiratory Synctial Virus Clinical Trials
3 recruiting trials for Respiratory Synctial Virus. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Respiratory Synctial Virus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of British Columbia (1), Fundacio Privada Mon Clinic Barcelona (1), Danderyd Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood sampling (other, 1 trial), followed by Mucosal sampling, PCR-test.
Track Respiratory Synctial Virus trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Infant RSV Immunity Study
Respiratory Syncytial Virus (RSV) is a main global cause of respiratory illness and death in infants. Previous infant vaccine trials have failed to demonstrate protection....
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
The goal of this observational study is to determine the prevalence of respiratory syncytial virus (RSV) infection and evaluate its association with clinical outcomes in patients...
COMMUNITY - the COVID-19 Immunity Study
The principal aim of the COMMUNITY study is to investigate immune responses following SARS-CoV-2 infection and/or vaccination in healthcare workers and hospitalized COVID-19...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Respiratory Synctial Virus, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Respiratory Synctial Virus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Respiratory Synctial Virus, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.